Please note that STAR Hospitals does not accept online payments and will never ask for an OTP over phone. Please make all payments directly at the hospital.
Dr. Chinna Babu Dracham

Consultant, Radiation-Oncology


Radiation Oncology

Education Qualifications
MBBS, Gandhi Medical College, Secunderabad
M.D. (Radiation Oncology): Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh

7 years
Consultant in Department of Radiation Oncology in Billroth Hospitals, Shenoy Nagar, and Dr. Rai Memorial Cancer Center, Teynampet, Chennai (2021-2023)
→ Assistant Professor in Department of Radiation Oncology from Government Cancer Hospital, Rajiv Gandhi Institute of Medical Sciences (RIMS), Kadapa, Andhra Pradesh (2021-2023)
Consultant in Department of Radiation Oncology in Queen’s NRI Hospital, Seethammadhara, Visakhapatnam (2019-2021)
Senior Resident Fellow Doctor, PGIMER, Regional Cancer Center, Chandigarh (2016-2019)

Field of Expertise
Treating gynecological cancers (cervix, endometrium, vagina and vulva)
Breast cancer
Lung cancer
Brain tumors
Gastrointestinal cancers (oesophagus, stomach, ano-rectum, liver, & pancreatic cancer)
Genito-urinary cancers (prostate, urinary bladder, penile and testicular cancer)
Soft tissue sarcoma and bone sarcoma
Pediatric tumor

Awards & Achievements
Awarded “International TRAVEL Fellowship” from Government of India, Department of Science and Technology (DST) – SERB, 2019.
Awarded “Abstract achievement award” at Multinational Association of Supportive Care in Cancer (MASCC), San Francisco, California, USA – 2019.
Received “Scholarship for Oral presentation in Proffered paper session” in ESMO – Head & Neck, Hong Kong – 2019.
Received “Scholarship for Oral presentation” in ESMO-ASIA, Singapore – 2018.
AROI – TRAVEL Fellowship award and “Silver Medal” in AROI – 2015.
Received “Best Abstract award for Oral presentation” in FHNO – 2015.

Research & Publications
Published Literature & Clinical Research in indexed Journals (PubMed & Google Scholar): Publications Citations: 245

1. Dracham CB, Kumar N, Kumar S, Elangovan A, Yadav BS, Mavuduru RS, Gupta PK, Kapoor R. A phase II study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer. Asian Journal of Urology. 2021 Jul 3.
2. Dracham CB, Khosla D, Kapoor R, Dey T, Periasamy K, Elangovan A, Madan R, Goyal S, Kumar N. Expanding role of radiotherapy in adenoid cystic carcinoma of the tracheobronchial tree: a new horizon. Tumori. 2021 May 12:3008916211012461. doi: 10.1177/03008916211012461. Epub ahead of print. PMID: 33977780.
3. Kumar N, Elangovan A, Madan R, Dracham CB, Khosla D, Tripathi M, Gupta K, Kapoor R. Impact of Immunohistochemical profiling of Glioblastoma multiforme on clinical outcomes: Real-world scenario in resource limited setting. Clin Neurol Neurosurg. 2021 Jun 4;207:106726. doi: 10.1016/j.clineuro.2021.106726. Epub ahead of print. PMID: 34116459.
4. Ghoshal S., Dracham CB., Sundaram A. et al. Prognostic Value of HPV Infection Assessed by p16 Immunohistochemistry and the Influence of Tobacco Usage in Oropharyngeal Cancers: Real World Scenario. Indian J Otolaryngol Head Neck Surg 2021.
5. Kumar N, Madan R, Dracham CB, Khosla D, Das N, Dey T, Elangovan A, Tripathi M, Gupta K, Ahuja C, Kapoor R. Multimodality treatment for Central Nervous System Germ Cell Tumors: Disease spectrum and evolution in management strategies. Clinical Neurology and Neurosurgery 2020.
6. Madan R., Dracham CB., Elangovan A. et al. Quality of Life Among Ovarian Cancer Survivors: A Tertiary Care Center Experience from India. Indian J Gynecol Oncolog 19, 3 (2021).
7. Kumar N, Madan R, Dracham CB, Chandran V, Elangovan A, Khosla D, Yadav BS, Kapoor R. Primary mediastinal germ cell tumors: Survival outcomes and prognostic factors – 10 years experience from a tertiary care institute. Rare Tumors. 2020 Nov 18;12:2036361320972220. doi: 10.1177/2036361320972220. PMID: 33282160; PMCID: PMC7682202.
8. Elangovan A, Dracham CB, Lokeswari A, Bharani V. Primary Transitional Cell Carcinoma of Fallopian Tube: A Rare Entity with Review of Literature.Global Journal of Medical Research, [S.l.], oct. 2020. ISSN 2249-4618. doi:
9. Kapoor R, Srinivasa GY, Das N, Dracham CB, Khosla D, Oinam AS. Dosimetric Evaluation of 3-Dimensional Conformal Radiotherapy Technique in Postoperative Patients with Gastric Carcinoma: When Is IMRT Really Needed?. Asian Pacific Journal of Cancer Care. 2020 Aug 15;5(3):151-6.
10. Elangovan A, Dracham CB, Muddabhaktuni MCB, Zaidi A. Primary broad ligament adenocarcinoma. Autops Case Rep [Internet]. 2020 Oct-Dec;10(4):e2020176.
11. Madan R, Dracham CB, Khosla D, Goyal S, Yadav AK. Erectile dysfunction and cancer: current perspective. Radiation Oncology Journal. 2020 Aug 26. doi :
12. Kumar N, Gy S, Dracham CB, Dey T, Madan R, Khosla D, Oinum A, Kapoor R. Can 3D-CRT meet the desired dose distribution to target and OARs in glioblastoma? A tertiary cancer center experience. CNS Oncol. 2020 Sep 1;9(3):CNS60. doi: 10.2217/cns-2020-0010. Epub 2020 Sep 18. PMID: 32945180; PMCID: PMC7546124.
13. Kapoor R, Dracham CB, G Y S, Khosla D, Dey T, Elangovan A, Madan R, Yadav BS, Kumar N. Clinical Outcomes and Prognostic Factors in Gastric Carcinoma Patients with Curative Surgery Followed by Adjuvant Treatment: Real-World Scenario. J Gastrointest Cancer. 2020 Jun 13. doi: 10.1007/s12029-020-00440-w. Epub ahead of print. PMID: 32535755.
14. Kapoor R, Dracham CB, Srinivasa GY, Gupta A. Expanding role of radiation in pancreatic tumors–A rare case report and a new horizon. International Journal of Noncommunicable Diseases. 2019 Jul 1;4(3):98.
15. Dracham CB, Gupta S, Das CK, Elangovan A. Platinum sensitive carcinoma of ovary relapsed as pericardial effusion with cardiac tamponade. BMJ Case Rep. 2019 Mar 22;12(3). pii: e228268. doi: 10.1136/bcr-2018-228268. PubMed PMID: 30904894.
16. Kumar N, Hanumanthappa N, Miriyala R, Vyas S, Salunke P, Oinam AS, Yadav BS, Madan R, Dracham CB, Kapoor R. Hurdles in radiation planning for glioblastoma: Can delayed-contrast enhanced computed tomography be a potential solution? Asia Pac J Clin Oncol. 2019 Jan 30. doi: 10.1111/ajco.13111. [Epub ahead of print] PubMed PMID: 30698349.
17. Bahl A, Elangovan A, Dracham CB, Kaur S, Oinam AS, Trivedi G, Verma R, Panda NK, Ghoshal S. Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy. Journal of experimental therapeutics & oncology. 2019 Jan 1;13(1).
18. Dracham CB, Elangovan A, Madan R, Gupta N. Primary extragonadal seminoma arising from the pelvis: A case report. African Journal of Urology. 2018 Dec 1;24(4):282-6.
19. Dracham CB, Mahajan R, Rai B, Elangovan A, Bhattacharya T, Ghoshal S. Toxicity and clinical outcomes with definitive three-dimensional conformal radiotherapy (3DCRT) and concurrent cisplatin chemotherapy in locally advanced cervical carcinoma. Jpn J Clin Oncol. 2018 Nov 17. doi: 10.1093/jjco/hyy164. [Epub ahead of print] PubMed PMID: 30452664.
20. Dracham CB, Shankar A, Madan R. Radiation induced secondary malignancies: a review article. Radiat Oncol J. 2018 Jun;36(2):85-94. doi: 10.3857/roj.2018.00290. Epub 2018 Jun 29. PubMed PMID: 29983028; PubMed Central PMCID: PMC6074073.
21. Miriyala R, Bansal A, Dracham CB, Thakur P, Ghoshal S. Diagnostic delay in oncology: Is there a need for increasing cancer awareness among primary care physicians of developing countries?. Ind J Soc Prev Rehab Onc 2018;2(1):1-8.
22. Shankar A, Dracham CB, Ghoshal S, Grover S. Prevalence of depression and anxiety disorder in cancer patients: An institutional experience. Indian J Cancer 2016;53:432-4.
23. Bansal A, Dracham CB, Teja R, Panda NK, Ghoshal S. Treatment Outcomes in Carcinoma Hypopharynx: An audit from a Regional Cancer Centre. Asian Journal of Radiation Oncology 2016; 5(1): 11.

Articles under Review

1. Bahl A, Dracham CB, Elangovan E, Rai B, Ghoshal S. Accelerated radiotherapy versus Conventional fractionation Radiotherapy in Cervical cancer (ACCORT)” Radiotherapy and Oncology 2022.

Research Projects Ongoing
1. Co-Principal investigator in multi center interventional Phase-I pilot project “Phase-I study of radiotherapy dose escalation using 68 Ga-Pentixafor PET/CT Scan in Glioblastoma patients and assessment of Quality of Life” with reference no: REF/2019/05/025690 and registered under Clinical Trial Registry of India (CTRI/2019/05/019146).
2. Contribution to a text book chapter titled “Palliative care in Paediatric Oncology” in Springer Nature Singapore Pte. Ltd. 2022 Publishing book titled “Evidence-based Practice in Paediatric Radiation Oncology”.

Abstracts published in indexed journals:

1. Madan R, Dracham CB, Elangovan A, Rai B, Ghoshal S. Assessment of sexual health in patients treated for ovarian cancer. Annals of Oncology. 2019 Nov 1;30:ix87.
2. Dracham CB, Madan R, Elangovan A, Rai B, Ghoshal S. Prospective assessment of quality of life in ovarian cancer survivors. Morressier; 2019 June 13. DOI:
3. Das N, Dracham CB, Madan R, Kumar N, Kapoor R. 285: The case for limited volume radiotherapy treatment in central nervous system germ cell tumor: A single centre experience. Paediatrics. J Can Res Ther 2019;15,Suppl S2:261-2.
4. Elangovan A, Bahl A, Patel FD, Dracham CB, Rai B, Trivedi G. Is bone marrow sparing intensity modulated radiotherapy better than 3-dimensional conformal radiotherapy in reducing haematological toxicities during pelvic irradiation in locally advanced carcinoma cervix?: A prospective study. Annals of Oncology. 2018 Nov 1;29:ix81-2.
5. Miriyala R, Bansal A, Dracham CB, Thakur P, Ghoshal S. 567P_PR Diagnostic delay in oncology: Is there a need for increasing cancer awareness among primary care physicians of developing countries?. Annals of Oncology. 2016 Dec 1;27:ix185.

Book an Appointment

We are glad that you preferred to contact us. Please fill our short form and one of our friendly team members will contact you back.

    Book an Appointment